Clinical utility and implementation of genomic newborn screening: findings from the SNUseq Baby Project
European Journal of Human Genetics (2026) Cite this article The screen-positive rate of genomic NBS was 1.3% for the inborn cohort, successfully identifying two patients with actionable metabolic and sensory disorders and three with high risk for genetic arrhythmia. Genomic data from…